| Symbol |
Name |
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADM
|
adrenomedullin
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADORA3
|
adenosine A3 receptor
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGGF1
|
angiogenic factor with G patch and FHA domains 1
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
AMOT
|
angiomotin
|
|
AMOTL2
|
angiomotin like 2
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPT4
|
angiopoietin 4
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
ANXA1
|
annexin A1
|
|
ANXA3
|
annexin A3
|
|
APLNR
|
apelin receptor
|
|
ATF4
|
activating transcription factor 4
|
|
ATP1B3
|
ATPase, Na+/K+ transporting, beta 3 polypeptide
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP6AP2
|
ATPase, H+ transporting, lysosomal accessory protein 2
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BMX
|
BMX non-receptor tyrosine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BSG
|
basigin (Ok blood group)
|
|
C1QTNF3
|
C1q and tumor necrosis factor related protein 3
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCL15
|
chemokine (C-C motif) ligand 15
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CD248
|
CD248 molecule, endosialin
|
|
CD276
|
CD276 molecule
|
|
CD34
|
CD34 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD93
|
CD93 molecule
|
|
CDC25B
|
cell division cycle 25B
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHGA
|
chromogranin A
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
CRIM1
|
cysteine rich transmembrane BMP regulator 1 (chordin-like)
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CTGF
|
connective tissue growth factor
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
CXCL6
|
chemokine (C-X-C motif) ligand 6
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DCLK1
|
doublecortin-like kinase 1
|
|
DCN
|
decorin
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3
|
|
DLL4
|
delta-like 4 (Drosophila)
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DYSF
|
dysferlin
|
|
EDIL3
|
EGF-like repeats and discoidin I-like domains 3
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGR1
|
early growth response 1
|
|
EGR3
|
early growth response 3
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
ENG
|
endoglin
|
|
EP300
|
E1A binding protein p300
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPHA1
|
EPH receptor A1
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FES
|
FES proto-oncogene, tyrosine kinase
|
|
FGF13
|
fibroblast growth factor 13
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFBP1
|
fibroblast growth factor binding protein 1
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FHL2
|
four and a half LIM domains 2
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXP1
|
forkhead box P1
|
|
GAS6
|
growth arrest-specific 6
|
|
GBP1
|
guanylate binding protein 1, interferon-inducible
|
|
GDF15
|
growth differentiation factor 15
|
|
GHRH
|
growth hormone releasing hormone
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GPC1
|
glypican 1
|
|
GPR4
|
G protein-coupled receptor 4
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GRP
|
gastrin-releasing peptide
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HDAC5
|
histone deacetylase 5
|
|
HDGF
|
hepatoma-derived growth factor
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HOXA5
|
homeobox A5
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HS6ST1
|
heparan sulfate 6-O-sulfotransferase 1
|
|
HS6ST2
|
heparan sulfate 6-O-sulfotransferase 2
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
IBSP
|
integrin-binding sialoprotein
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA2
|
interferon, alpha 2
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IL10
|
interleukin 10
|
|
IL18
|
interleukin 18
|
|
IL19
|
interleukin 19
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
ILK
|
integrin-linked kinase
|
|
INS
|
insulin
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB5
|
integrin, beta 5
|
|
ITGB8
|
integrin, beta 8
|
|
ITLN1
|
intelectin 1 (galactofuranose binding)
|
|
JAG1
|
jagged 1
|
|
JAK2
|
Janus kinase 2
|
|
JAM3
|
junctional adhesion molecule 3
|
|
JMJD6
|
jumonji domain containing 6
|
|
KDM5B
|
lysine (K)-specific demethylase 5B
|
|
KDR
|
kinase insert domain receptor
|
|
KITLG
|
KIT ligand
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KNG1
|
kininogen 1
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LEP
|
leptin
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LIMK1
|
LIM domain kinase 1
|
|
LNPEP
|
leucyl/cystinyl aminopeptidase
|
|
LVRN
|
laeverin
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MEOX2
|
mesenchyme homeobox 2
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFAP5
|
microfibrillar associated protein 5
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR1-1
|
microRNA 1-1
|
|
MIR10A
|
microRNA 10a
|
|
MIR126
|
microRNA 126
|
|
MIR130A
|
microRNA 130a
|
|
MIR132
|
microRNA 132
|
|
MIR155
|
microRNA 155
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR17
|
microRNA 17
|
|
MIR182
|
microRNA 182
|
|
MIR19B1
|
microRNA 19b-1
|
|
MIR20A
|
microRNA 20a
|
|
MIR21
|
microRNA 21
|
|
MIR27B
|
microRNA 27b
|
|
MIR29A
|
microRNA 29a
|
|
MIR424
|
microRNA 424
|
|
MIR92A1
|
microRNA 92a-1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP10
|
matrix metallopeptidase 10
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYO1C
|
myosin IC
|
|
NAB2
|
NGFI-A binding protein 2 (EGR1 binding protein 2)
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NES
|
nestin
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NOL7
|
nucleolar protein 7, 27kDa
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOTCH4
|
notch 4
|
|
NOV
|
nephroblastoma overexpressed
|
|
NOX4
|
NADPH oxidase 4
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRP1
|
neuropilin 1
|
|
NRP2
|
neuropilin 2
|
|
NTN1
|
netrin 1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
PARG
|
poly (ADP-ribose) glycohydrolase
|
|
PAX2
|
paired box 2
|
|
PCGF2
|
polycomb group ring finger 2
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFC
|
platelet derived growth factor C
|
|
PDGFD
|
platelet derived growth factor D
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PF4
|
platelet factor 4
|
|
PF4V1
|
platelet factor 4 variant 1
|
|
PGF
|
placental growth factor
|
|
PHACTR1
|
phosphatase and actin regulator 1
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLG
|
plasminogen
|
|
PLXDC1
|
plexin domain containing 1
|
|
PLXNB1
|
plexin B1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PREX1
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRL
|
prolactin
|
|
PROK1
|
prokineticin 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTN
|
pleiotrophin
|
|
PTPN23
|
protein tyrosine phosphatase, non-receptor type 23
|
|
PTPRJ
|
protein tyrosine phosphatase, receptor type, J
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
RAB25
|
RAB25, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RCAN1
|
regulator of calcineurin 1
|
|
RNF213
|
ring finger protein 213
|
|
RPL19
|
ribosomal protein L19
|
|
RRAS
|
related RAS viral (r-ras) oncogene homolog
|
|
RUNX2
|
runt-related transcription factor 2
|
|
S100A13
|
S100 calcium binding protein A13
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
SBSN
|
suprabasin
|
|
SDC1
|
syndecan 1
|
|
SELE
|
selectin E
|
|
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
|
|
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SHB
|
Src homology 2 domain containing adaptor protein B
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SIRT1
|
sirtuin 1
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SMAD3
|
SMAD family member 3
|
|
SMOC2
|
SPARC related modular calcium binding 2
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOX11
|
SRY (sex determining region Y)-box 11
|
|
SP1
|
Sp1 transcription factor
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STC1
|
stanniocalcin 1
|
|
STC2
|
stanniocalcin 2
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TARS
|
threonyl-tRNA synthetase
|
|
TBXAS1
|
thromboxane A synthase 1 (platelet)
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
THBS1
|
thrombospondin 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TP53
|
tumor protein p53
|
|
TPSAB1
|
tryptase alpha/beta 1
|
|
TRPC4
|
transient receptor potential cation channel, subfamily C, member 4
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSPO
|
translocator protein (18kDa)
|
|
TXNDC5
|
thioredoxin domain containing 5 (endoplasmic reticulum)
|
|
TYMP
|
thymidine phosphorylase
|
|
UTS2
|
urotensin 2
|
|
VASH1
|
vasohibin 1
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFB
|
vascular endothelial growth factor B
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT2
|
wingless-type MMTV integration site family member 2
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
ZC3H12A
|
zinc finger CCCH-type containing 12A
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
